FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marianne Callahan

Research Profile

Chemicals & Drugs

Anatomy

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Christine K Mauck; Susan A Ballagh; Mitchell Creinin; Debra H Weiner; Gustavo F Doncel; Raina N Fichorova; Jill L Schwartz; Neelima Chandra; Marianne M Callahan
Six-day randomized safety trial of intravaginal lime juice.
Jill L Schwartz; Susan A Ballagh; Mitchell Creinin; Robert W Rountree; Maggie Kilbourne-Brook; Christine K Mauck; Marianne M Callahan
SILCS diaphragm: postcoital testing of a new single-size contraceptive device.
Jill L Schwartz; George Kovalevsky; Jaim-Jou Lai; Susan A Ballagh; Timothy McCormick; Karen Douville; Christine K Mauck; Marianne M Callahan
A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marianne Callahan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Christine K Mauck; Susan A Ballagh; Mitchell Creinin; Debra H Weiner; Gustavo F Doncel; Raina N Fichorova; Jill L Schwartz; Neelima Chandra; Marianne M Callahan
Six-day randomized safety trial of intravaginal lime juice.
Journal of acquired immune deficiency syndromes (1999) 2008;49(3):243-50.
2008: Jill L Schwartz; Susan A Ballagh; Mitchell Creinin; Robert W Rountree; Maggie Kilbourne-Brook; Christine K Mauck; Marianne M Callahan
SILCS diaphragm: postcoital testing of a new single-size contraceptive device.
Contraception 2008;78(3):237-44.
2008: Jill L Schwartz; George Kovalevsky; Jaim-Jou Lai; Susan A Ballagh; Timothy McCormick; Karen Douville; Christine K Mauck; Marianne M Callahan
A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor.
Sexually transmitted diseases 2008;35(4):414-9.
2008: Christine K Mauck; Ron G Freziers; Terri L Walsh; Karen Peacock; Jill L Schwartz; Marianne M Callahan
Noncomparative contraceptive efficacy of cellulose sulfate gel.
Obstetrics and gynecology 2008;111(3):739-46.
2008: Susan A Ballagh; Vivian Brache; Christine K Mauck; Marianne M Callahan; Leila Cochon; Angie Wheeless; Thomas R Moench
A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet.
Contraception 2008;77(2):130-7.
2007: Jill L Schwartz; Susan A Ballagh; Cynthia Kwok; Christine K Mauck; Debra H Weiner; William F Rencher; Marianne M Callahan
Fourteen-day safety and acceptability study of the universal placebo gel.
Contraception 2007;75(2):136-41.
2006: Jose A Simoes; Luis Bahamondes; Rodrigo P S Camargo; Valeria M N Alves; Lourens J D Zaneveld; Donald Paul Waller; Jill Schwartz; Marianne M Callahan; Christine K Mauck
A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.
British journal of clinical pharmacology 2006;61(2):211-7.
2006: Christine K Mauck; Debra H Weiner; Mitchell Creinin; David F Archer; Jill L Schwartz; Helen C Pymar; Susan A Ballagh; Deborah M Henry; Marianne M Callahan
FemCap with removal strap: ease of removal, safety and acceptability.
Contraception 2006;73(1):59-64.
2005: Christine K Mauck; Mitchell Creinin; Wes Rountree; Marianne M Callahan; Sharon L Hillier
Lea's Shield: colposcopic and microbiological testing during 8 weeks of use.
Contraception 2005;72(1):53-9.
2005: Jill L Schwartz; Alfred Poindexter; Susan W Schmitz; Christine K Mauck; Marianne M Callahan
Male tolerance of ACIDFORM gel.
Contraception 2005;71(6):443-6.
2004: Susan A Ballagh; Christine K Mauck; Deborah Henry; David F Archer; Theresa Abercrombie; Marianne M Callahan; Henry L Gabelnick
A comparison of techniques to assess cervicovaginal irritation and evaluation of the variability between two observers.
Contraception 2004;70(3):241-9.
2004: Christine K Mauck; Debra H Weiner; Mitchell Creinin; Kurt T Barnhart; Marianne M Callahan; Richard Bax
A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II.
Contraception 2004;70(3):233-40.
2004: Christine K Mauck; Mitchell Creinin; Kurt T Barnhart; Susan A Ballagh; David F Archer; Marianne M Callahan; Susan W Schmitz; Richard Bax
A phase I comparative postcoital testing study of three concentrations of C31G.
Contraception 2004;70(3):227-31.
2004: Christine K Mauck; Ron G Frezieres; Terri L Walsh; Susan W Schmitz; Marianne M Callahan; Richard Bax
Male tolerance study of 1% C31G.
Contraception 2004;70(3):221-5.
2004: Christine K Mauck; Debra H Weiner; Susan A Ballagh; Mitchell Creinin; David F Archer; Jill L Schwartz; Helen C Pymar; Jaim-Jou Lai; William F Rencher; Marianne M Callahan
Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.
Contraception 2004;70(1):77-83.
2003: Stephen R Tabet; Marianne M Callahan; Christine K Mauck; Fang Gai; Anne S Coletti; Albert T Profy; Thomas R Moench; Lydia Soto-Torres; Alfred N Poindexter III; Ron G Frezieres; Terri L Walsh; Clifton W Kelly; Barbra A Richardson; Lut Van Damme; Connie Celum
Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men.
Journal of acquired immune deficiency syndromes (1999) 2003;33(4):476-83.
1999: Christine K Mauck; Marianne M Callahan; J Baker; K Arbogast; R Veazey; R Stock; Z Pan; C S Morrison; M Chen-Mok; David F Archer; Henry L Gabelnick
The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.
Contraception 1999;60(1):15-24.